CapsoVision

CVNasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$354.741 M

$7.10 +2.90%

Close of 7 Aug 2026

Revenue

$13.6M

#3107 by revenue

Earnings

-$25.3M

Loss-making

Shares outstanding

49,838,211

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus — ranked by market cap

All 28 →

#8InModeINMD$970.0M
#9CeribellCBLL$713.7M
#10CapsoVisionCV$354.7M
#11ElectromedELMD$349.3M
#12Edap TmsFOCL$233.2M

Where these numbers come from

Share counts and financials for CapsoVision are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.